GRAS Associates Receives FDA “No Questions” GRAS Notice Letter for OraTicx’s Probiotic Ingredient

June 06, 2023

 GRAS Associates Receives FDA “No Questions” GRAS Notice Letter for OraTicx’s Probiotic Ingredient

Successful notification for Weissella cibaria CMU as an ingredient in various food products, paving the way for global market entry of oraCMU® oral probiotic.

Read More

NASC Announces Successful Tolerability Study of Cannabidiol Products in Healthy Dogs

May 16, 2023

NASC Announces Successful Tolerability Study of Cannabidiol Products in Healthy Dogs

Collaborative Study with Nutrasource Evaluates Tolerability of Supplementation and Determine Safe Dosage

Read More

SGS Acquires a Majority Stake in Nutrasource

May 11, 2023

SGS Acquires a Majority Stake in Nutrasource

The initial investment is 60% of shares of Nutrasource, with the right to acquire the remaining 40% of shares in 2026.

Read More

Korean Health Supplements Association (KHSA) Approves Use of IFOS™ Logo on Korean Manufactured Omega-3 Product Packaging

April 11, 2023

Korean Health Supplements Association (KHSA) Approves Use of IFOS™ Logo on Korean Manufactured Omega-3 Product Packaging

Approval is a First for Korean Manufactured Supplement Products

Read More

Apex Trials Joins hyperCORE International's Clinical Trial Network

January 30, 2023

Apex Trials Joins hyperCORE International's Clinical Trial Network

The partnership will bring hyperCORE new and expanded capabilities in health product development, including dietary supplements, medical foods and devices, biologics, and other pharmaceuticals.

Read More

Global CRO Nutrasource Rebrands Clinical Trial Site to Apex Trials

January 23, 2023

Global CRO Nutrasource Rebrands Clinical Trial Site to Apex Trials

Move expands and increases opportunities for studies in both pharmaceutical and nutraceutical industries

Read More

Nutrasource Announces NutraStrong™ Certification Program

October 24, 2022

Nutrasource Announces NutraStrong™  Certification Program

October marks the launch of NutraStrong™, a new global certification program.

Read More

Nutrasource Announces FDA Approval of Investigational New Drug (IND) Applications for n-Lorem Foundation

September 23, 2022

Nutrasource Announces FDA Approval of Investigational New Drug (IND) Applications for n-Lorem Foundation

Investigator IND / Research (Non-commercial)

Read More

Chenland Nutritionals, Supported by Nutrasource, Receives Self Affirmed GRAS for CuminUP60® Ingredient

August 09, 2022

Chenland Nutritionals, Supported by Nutrasource, Receives Self Affirmed GRAS for CuminUP60® Ingredient

The company attained the self-designation with assistance of GRAS Associates/Nutrasource

Read More

Kelai Pharmaceutical LLC selects Nutrasource to Support Its Drug Development Program

July 26, 2022

Kelai Pharmaceutical LLC selects Nutrasource to Support Its  Drug Development Program

Kelai Pharmaceutical LLC selects Nutrasource to Support Its Drug Development Program

Read More